Clinical significance of sarcopenia in patients undergoing treatment for gastric cancer.

Autor:	Ozcan SGG; Bursa Yuksek Ihtisas Education and Research Hospital, Department of Radiology - Bursa, Turkey., Kacan T; Doruk Hospital, Department of Medical Oncology - Bursa, Turkey., Kacmaz NK; Bursa Yuksek Ihtisas Education and Research Hospital, Department of Radiology - Bursa, Turkey., Gundogan B; Bursa Yuksek Ihtisas Education and Research Hospital, Department of Internal Medicine - Bursa, Turkey., Vurgec IH; Bursa Yuksek Ihtisas Education and Research Hospital, Department of Internal Medicine - Bursa, Turkey., Ozyildirim S; Bursa Yuksek Ihtisas Education and Research Hospital, Department of General Surgery - Bursa, Turkey.
Jazyk:	angličtina
Zdroj:	Revista da Associacao Medica Brasileira (1992) [Rev Assoc Med Bras (1992)] 2023 Nov 13; Vol. 69 (12), pp. e20230568. Date of Electronic Publication: 2023 Nov 13 (Print Publication: 2023).
DOI:	10.1590/1806-9282.20230568
Abstrakt:	Objective: The aim of this study was to investigate the impact of sarcopenia on prognosis in patients with gastric cancer in order to explore the relationship between sarcopenia and postoperative complications as well as durations of hospital stay and intensive care unit. Methods: A total of 175 patients who visited the oncology clinic between 2017 and 2022 with respect to their radiological images, demographic data, and laboratory parameters were perused. The OsiriX software was used to measure the skeletal muscle area that was divided by the body height in order to obtain the skeletal muscle index. Results: A total of 50.28% of 175 patients (41 females and 134 males, with a mean age of 63.5 years) who met the inclusion criteria in the study were sarcopenic. Significant differences appeared between sarcopenic and non-sarcopenic patients with respect to durations of both hospital stay (p<0.01) and intensive care unit stay (p<0.01) (multivariate analysis). Furthermore, patients with sarcopenia had significantly frequent postoperative complications in comparison with those without sarcopenia. Among the patients with sarcopenia, decreased levels of hemoglobin and albumin as well as lymphocytes were encountered in terms of inflammatory markers; nevertheless, no significant differences were determined among other inflammatory markers. Conclusion: In patients undergoing treatment for gastric cancer, sarcopenia increases postoperative complications and prolongs hospital and intensive care stays during the treatment process.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu